Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mechanism of afatinib resistance in non-small cell lung cancer patients with nonclassical EGFR mutations: A multicenter, retrospective study.

Medicine·2026

Same author

A phenome-wide association study reveals novel phenotypic determinants of migraine risk in the UK Biobank.

Headache·2026

Same author

Near-infrared light-triggered, self-amplifying targeted drug-delivery platform achieves precision treatment of retinoblastoma.

International journal of pharmaceutics·2026

Same author

An exploratory ImmunoScore based on early on-treatment changes in NLR and LDH in small-cell lung cancer receiving first-line chemoimmunotherapy.

Future oncology (London, England)·2026

Same author

Genetic and clinical investigation of insulin-degrading enzyme in Parkinson's disease within the Chinese Han population.

Frontiers in neuroscience·2026

Same author

Design of Ion-Pairing Azithromycin liposome for Local Pulmonary Delivery with Prolonged Lung Retention.

AAPS PharmSciTech·2026

Search research articles

Related Experiment Video

Updated: Jul 24, 2025

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

Myasthenia Gravis and Ischemic Stroke: A Bidirectional Mendelian Randomization Study.

Chen Liu^1,2,3,4, Chengyuan Mao^1,3,4, Shen Li^1,2,3,4

¹Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.

Current Neurovascular Research

|July 5, 2023

Summary

This study investigated if myasthenia gravis (MG) causes ischemic stroke (IS). Mendelian randomization analysis found no evidence of a causal link between MG and IS, or vice versa.

Keywords:

Myasthenia gravis causal link genetics ischemic stroke mendelian randomization single nucleotide polymorphism

More Related Videos

Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery

Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery

Published on: May 24, 2021

Modeling Stroke in Mice - Middle Cerebral Artery Occlusion with the Filament Model

Modeling Stroke in Mice - Middle Cerebral Artery Occlusion with the Filament Model

Published on: January 6, 2011

Related Experiment Videos

Last Updated: Jul 24, 2025

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery

Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery

Published on: May 24, 2021

Modeling Stroke in Mice - Middle Cerebral Artery Occlusion with the Filament Model

Modeling Stroke in Mice - Middle Cerebral Artery Occlusion with the Filament Model

Published on: January 6, 2011

Area of Science:

Neurology
Immunology
Cardiovascular Science

Background:

Autoimmune diseases are linked to cardiovascular and cerebrovascular conditions.
The potential causal relationship between myasthenia gravis (MG) and ischemic stroke (IS) remains uncertain.

Conclusions:

Bidirectional Mendelian randomization analysis did not support a causal relationship between genetically predicted myasthenia gravis and ischemic stroke.
Findings contrast with some observational studies, highlighting the importance of genetic evidence in establishing causality.